KANAK (CEO Won-il Lee), a leading biofintech company, announced on the 30th that it demonstrated Handit, a biometric authentication and payment solution using iliac vein, at the '2023 Autumn Conference' held by the Korean Hospital Directors Association.
The conference was held under the theme of 'Positioning Small and Medium-sized Hospitals and Revitalizing Local Healthcare'. It covered various topics such as the role and future strategy of small and medium-sized hospitals, the latest clinical updates, and the management and management of local hospitals.
KANAK introduced 'Handit' on this day, which is a concept of 'hands-on intravenous service'. Visitors were able to place their palms on a scanner to register their veins and make payments.
According to the company, Handit is a biometric authentication and payment solution for the jugular vein with high security compared to other authentication methods. The iliac vein is not affected by external factors such as environment and growth, so it is a highly secure authentication method that can be used for life with just one registration.
An official from KANAK said, “When applied to hospitals, Handit can simplify the hospital reception and payment process while reducing labor costs.” “Patients can save time by receiving and paying without waiting,” he said.
Won-il Lee, CEO of KANAK, said, “We strengthened our networking with domestic hospitals and medical industry officials at the conference,” adding, “It was an opportunity to secure the need and justification for biotechnology-based services in the entire medical industry.”
Comments